Know Cancer

or
forgot password


Phase 3
N/A
N/A
Not Enrolling
Both
Carcinoma, Non-Small-Cell Lung

Thank you

Trial Information


Inclusion Criteria:



- Patients with early stage NSCLC

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

OS, MS, DFS

Outcome Time Frame:

overall

Safety Issue:

No

Principal Investigator

Khalid Rehman, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

King Faisal Specialist Hospital & Research Centre, Saudi Arabia

Authority:

United States: Institutional Review Board

Study ID:

RAC#2031-059

NCT ID:

NCT00540280

Start Date:

October 2003

Completion Date:

October 2013

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • NSCLC
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung

Name

Location